To determine the prevalence and characteristics of pain in symptomatic and asymptomatic patients with HTLV-1, for HAM/TSP, Cross-sectional study conducted in patients with HTLV seen at a referral center for patient care and research in Salvador, Bahia, Brazil. Sociodemographic data were evaluated by means of interviews. The presence of neuropathic pain was evaluated by the DN4 questionnaire, its intensity by the Visual Analog Scale and its location by the body map, Among the 115 patients, 84.3% complained of pain. The most affected locations were the lumbar spine and lower limbs (63.1%). Of these 46.1% presented defined or probable HAM/TSP. There was no association between the type of pain and presence of HAM/TSP, but symptomatic patients h...
AbstractThe purpose of this review is to present some concepts on the etiology of tropical spastic p...
We performed a comprehensive clinical and neurophysiological evaluation of function of the large- an...
International audienceHuman T-cell leukemia/lymphoma virus-1 (HTLV-1), the first human oncoretroviru...
HTLV-1 is the causal agent of HTLV-1-associated myelopathy/tropical spastic para...
Tropical Spastic Paraparesis (TSP) is an uncommon myeloneuropathy with an insular geographic distrib...
In this study, the epidemiological and clinical features observed in solely HTLV-II-infected individ...
Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) i...
SUMMARY- HTLV-I associated myelopathy/tropical spastic paraparesis (TSP/HAM) have been increasingly ...
AbstractObjectiveTo describe the pain in patients infected with human T-cell lymphotropic virus type...
Ten possible cases of tropical spastic paraparesis (TSP) in Northeastern Brazil (Ceará) are presente...
<b>Background</b>: Community-based neurological data about human T lymphotropic virus ty...
Background. Human T-cell lymphotropic virus type 1 (HTLV-1) is the agent of HTLV-1–associated myelop...
p.257-261OBJECTIVE: To assess the quality of life (QoL) of patients with HTLV-I-associate myelopathy...
Abstract INTRODUCTION: Human T-cell lymphotropic virus type 1-associated myelopathy or tropical sp...
Hospital-ship San Raffael of the Italian-Colombian Foundation of Monte Tabor develops a social and h...
AbstractThe purpose of this review is to present some concepts on the etiology of tropical spastic p...
We performed a comprehensive clinical and neurophysiological evaluation of function of the large- an...
International audienceHuman T-cell leukemia/lymphoma virus-1 (HTLV-1), the first human oncoretroviru...
HTLV-1 is the causal agent of HTLV-1-associated myelopathy/tropical spastic para...
Tropical Spastic Paraparesis (TSP) is an uncommon myeloneuropathy with an insular geographic distrib...
In this study, the epidemiological and clinical features observed in solely HTLV-II-infected individ...
Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) i...
SUMMARY- HTLV-I associated myelopathy/tropical spastic paraparesis (TSP/HAM) have been increasingly ...
AbstractObjectiveTo describe the pain in patients infected with human T-cell lymphotropic virus type...
Ten possible cases of tropical spastic paraparesis (TSP) in Northeastern Brazil (Ceará) are presente...
<b>Background</b>: Community-based neurological data about human T lymphotropic virus ty...
Background. Human T-cell lymphotropic virus type 1 (HTLV-1) is the agent of HTLV-1–associated myelop...
p.257-261OBJECTIVE: To assess the quality of life (QoL) of patients with HTLV-I-associate myelopathy...
Abstract INTRODUCTION: Human T-cell lymphotropic virus type 1-associated myelopathy or tropical sp...
Hospital-ship San Raffael of the Italian-Colombian Foundation of Monte Tabor develops a social and h...
AbstractThe purpose of this review is to present some concepts on the etiology of tropical spastic p...
We performed a comprehensive clinical and neurophysiological evaluation of function of the large- an...
International audienceHuman T-cell leukemia/lymphoma virus-1 (HTLV-1), the first human oncoretroviru...